{"product_id":"university-of-miami-neurology-update-and-stroke-intensive-review-2023","title":"University of Miami Neurology Update and Stroke Intensive Review 2023","description":"\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003ch1 class=\"product_title entry-title\"\u003eUniversity of Miami Neurology Update and Stroke Intensive Review 2023\u003c\/h1\u003e\r\n\u003cstrong\u003e+ Include: 54 videos, size: 16.3 GB\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Target Audience: neurologists, stroke specialists, neurosurgeons, psychiatrists, neuro-oncologists, hospitalists, intensivists, fellows, residents\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Information:\u003c\/strong\u003e\r\n\u003cdiv class=\"form-group\"\u003e\r\n\u003cdiv class=\"form-control-plaintext\"\u003e\r\n\u003cdiv class=\"form-group\"\u003e\r\n\r\nUniversity of Miami’s Annual Neurology Update and Stroke Intensive Review 2023 will be held January 25-28, 2023 in Miami, Florida.\r\n\r\nThe 56th Annual Neurology Update and Stroke Intensive Review 2023 provides clinicians with a comprehensive review of the most recent developments in the diagnosis and management of neurologic disorders, including stroke, cognitive neurology\/brain health, epilepsy, multiple sclerosis (MS), movement disorders, neuromuscular disorders, headache\/migraine, neuro-oncology, neuropsychology, sleep disorders and general neurology.\r\n\r\nA dedicated stroke seminar will take place on January 28, 2023 and is designed as a stand-alone 8-hour activity. For those centers planning to seek stroke center status or already designated as a stroke center, this course will provide stroke teams with the most up-to-date evidence in the field of stroke diagnosis, treatment and prevention\r\n\r\nChallenging diagnostic and therapeutic questions will be raised in each session around representative clinical vignettes, targeted reviews of the topic by the faculty and panel discussions. Exchange of information between faculty and attendees will take place during questions and answers sessions after each presentation as well as round table and panel discussions.\r\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eThe course is aimed primarily at neurologists, stroke specialists,  neurosurgeons, psychiatrists, neuro-oncologists, hospitalists, intensivists,  fellows, residents, nurses and allied healthcare professionals that participate in the care of neurological patients or work in stroke centers. Internists,  general practitioners and cardiologists may also find the topics timely  and useful.\u003c\/p\u003e\r\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003e\u003cstrong\u003eLEARNING OBJECTIVES\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cdiv class=\"Classes__sectionContainer___1cH9Y \"\u003e\r\n\u003cdiv class=\"Grid__row___2u_GY Grid__small___3wtn0\"\u003e\r\n\u003cdiv class=\"Grid__column___2wm6q Grid__col_12___17Qv4 Grid__small___3wtn0\"\u003e\r\n\u003cdiv class=\"Grid__row___2u_GY Grid__small___3wtn0\"\u003e\r\n\u003cdiv class=\"Grid__column___2wm6q Grid__col_12___17Qv4 Grid__small___3wtn0\"\u003e\r\n\u003cdiv id=\"widget:bc212cc7-6ba7-45c5-ac8b-a70398ec3c02\" class=\"App__widgetIdcontainer___2lz3a\"\u003e\r\n\u003cdiv class=\"Text__container___1phUc\" data-cvent-id=\"widget-NucleusText-widget:bc212cc7-6ba7-45c5-ac8b-a70398ec3c02\"\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"css-vsf5of\"\u003e\r\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eAt the completion of the course, attendees will be able to:\u003c\/p\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv class=\"Classes__sectionContainer___1cH9Y \"\u003e\r\n\u003cdiv class=\"Grid__row___2u_GY Grid__small___3wtn0\"\u003e\r\n\u003cdiv class=\"Grid__column___2wm6q Grid__col_6___3aN9b Grid__small___3wtn0\"\u003e\r\n\u003cdiv class=\"Grid__row___2u_GY Grid__small___3wtn0\"\u003e\r\n\u003cdiv class=\"Grid__column___2wm6q Grid__col_12___17Qv4 Grid__small___3wtn0\"\u003e\r\n\u003cdiv id=\"widget:ee3f920c-b73b-494d-abe1-0e2aaea2a496\" class=\"App__widgetIdcontainer___2lz3a\"\u003e\r\n\u003cdiv class=\"Text__container___1phUc\" data-cvent-id=\"widget-NucleusText-widget:ee3f920c-b73b-494d-abe1-0e2aaea2a496\"\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"css-vsf5of\"\u003e\r\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eCOGNITIVE NEUROLOGY\u003c\/p\u003e\r\n\r\n\u003cul class=\"carina-rte-public-DraftStyleDefault-ul\"\u003e\r\n \t\u003cli\u003eExplain precision medicine approaches to create personalized care plans to promote brain health and manage individuals living with neurodegenerative disease\u003c\/li\u003e\r\n \t\u003cli\u003eApply concepts of care teams to optimize patient outcomes\u003c\/li\u003e\r\n \t\u003cli\u003eExplain novel research advances and how these may influence the neurology practice\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eEPILEPSY\u003c\/p\u003e\r\n\r\n\u003cul class=\"carina-rte-public-DraftStyleDefault-ul\"\u003e\r\n \t\u003cli\u003ePrescribe the newest third generation antiseizure medications for the treatment of focal and generalized epilepsy and Lennox Gastaut Syndrome\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize when neuromodulation therapies with Deep Brain Stimulation and   Responsive Neurostimulation are indicated for the treatment of refractory epilepsy\u003c\/li\u003e\r\n \t\u003cli\u003eSelect patients with temporal lobe epilepsy who can be ideal candidates for laser ablation of mesial temporal structures\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eGENERAL NEUROLOGY\u003c\/p\u003e\r\n\r\n\u003cul class=\"carina-rte-public-DraftStyleDefault-ul\"\u003e\r\n \t\u003cli\u003eApply Optical Coherence Tomography in diagnosing visual pathway problems\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify common neurological symptoms of mild traumatic brain injury and develop an approach for management\u003c\/li\u003e\r\n \t\u003cli\u003eExamine current uses of deep learning in neurology\u003c\/li\u003e\r\n \t\u003cli\u003eReview the common causes and epidemiology of Spinal Cord Injury (SCI)\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize the symptoms and the treatment of Autonomic Dysreflexia in persons with SCI\r\nDefine the criteria for death by neurologic criteria\/brain death\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eHEADACHE\/MIGRAINE\u003c\/p\u003e\r\n\r\n\u003cul class=\"carina-rte-public-DraftStyleDefault-ul\"\u003e\r\n \t\u003cli\u003eIdentify, diagnose and initiate treatment of common presentations of pediatric migraine and pisodic syndromes that may be associated with migraine\u003c\/li\u003e\r\n \t\u003cli\u003eExamine the role of headaches in cerebrovascular diseases\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify the appropriate diagnosis and treatment for various headache disorders      including less common and refractory migraine types with focus on recent advancements, integrative strategies and patient-centered management\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate the approach to headache and vascular disease in mid-life and older populations, including safer treatment options in high risk populations\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eMOVEMENT DISORDERS\u003c\/p\u003e\r\n\r\n\u003cul class=\"carina-rte-public-DraftStyleDefault-ul\"\u003e\r\n \t\u003cli\u003ePresent the latest diagnostic criteria and treatments for Parkinson’s disease\u003c\/li\u003e\r\n \t\u003cli\u003eOutline the motor and nonmotor fluctuations that complicate Parkinson’s   disease symptoms.\u003c\/li\u003e\r\n \t\u003cli\u003eDelineate the diagnosis and treatment of ET and its mimickers\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eMULTIPLE SCLEROSIS\u003c\/p\u003e\r\n\r\n\u003cul class=\"carina-rte-public-DraftStyleDefault-ul\"\u003e\r\n \t\u003cli\u003eDiagnose and treat Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD)\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate cognitive impairment in Multiple Sclerosis (MS) patients during routine clinical screenings\u003c\/li\u003e\r\n \t\u003cli\u003eAnalyze the safety and use of disease modifying treatments in patients with Multiple Sclerosis and NMOSD during pregnancy and breastfeeding.\u003c\/li\u003e\r\n \t\u003cli\u003eExplore means by which diet, gut health and lifestyle factors can impact the overall health and well-being of patients with MS\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify the typical brain MS lesions and review radiological MS mimics\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003cdiv class=\"Grid__column___2wm6q Grid__col_6___3aN9b Grid__small___3wtn0\"\u003e\r\n\u003cdiv class=\"Grid__row___2u_GY Grid__small___3wtn0\"\u003e\r\n\u003cdiv class=\"Grid__column___2wm6q Grid__col_12___17Qv4 Grid__small___3wtn0\"\u003e\r\n\u003cdiv id=\"widget:d12702f0-61f9-4296-998f-36c909fb06fc\" class=\"App__widgetIdcontainer___2lz3a\"\u003e\r\n\u003cdiv class=\"Text__container___1phUc\" data-cvent-id=\"widget-NucleusText-widget:d12702f0-61f9-4296-998f-36c909fb06fc\"\u003e\r\n\u003cdiv\u003e\r\n\u003cdiv class=\"css-vsf5of\"\u003e\r\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eNEUROMUSCULAR DISORDERS\u003c\/p\u003e\r\n\r\n\u003cul class=\"carina-rte-public-DraftStyleDefault-ul\"\u003e\r\n \t\u003cli\u003eSummarize the recent identification of autoantibodies associated with inflammatory neuropathies and review their correlation with clinical presentation and treatment response\u003c\/li\u003e\r\n \t\u003cli\u003eOutline an approach to the diagnosis of myositis based on autoantibody profiling\u003c\/li\u003e\r\n \t\u003cli\u003eReview the recent completed clinical trials for ALS\u003c\/li\u003e\r\n \t\u003cli\u003eOutline the landscape of future studies in development for ALS\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eNEUROPSYCHOLOGY\u003c\/p\u003e\r\n\r\n\u003cul class=\"carina-rte-public-DraftStyleDefault-ul\"\u003e\r\n \t\u003cli\u003eDefine frailty and its association with cognition in middle- and older-life and   suggestions for incorporating frailty screening as part of a physical examination\u003c\/li\u003e\r\n \t\u003cli\u003eExamine appropriate non-pharmacological interventions for patients with   cognitive disorders •Describe disparities in sleep and cognitive disorders and how to address   these in practice\u003c\/li\u003e\r\n \t\u003cli\u003eAugment awareness and competence in the factors that influence quality of   life in neurological practice\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eNEURO-ONCOLOGY\u003c\/p\u003e\r\n\r\n\u003cul class=\"carina-rte-public-DraftStyleDefault-ul\"\u003e\r\n \t\u003cli\u003eEvaluate diagnostic advances for brain tumor patients\u003c\/li\u003e\r\n \t\u003cli\u003eRecommend multidisciplinary treatment for brain tumor patients Identify challenges in the care of brain tumor patients\u003c\/li\u003e\r\n \t\u003cli\u003eAnalyze the epidemiology, clinical presentation, neuropathology, diagnosis, and treatment options for gliomas\u003c\/li\u003e\r\n \t\u003cli\u003eAnalyze the epidemiology, clinical presentation, neuropathology, diagnosis, and treatment options for adolescents and young adults with brain tumors\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate therapeutic advances for brain tumor patients\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eSLEEP DISORDERS\u003c\/p\u003e\r\n\r\n\u003cul class=\"carina-rte-public-DraftStyleDefault-ul\"\u003e\r\n \t\u003cli\u003eExamine the effect of sleep disorders on brain health outcomes, such as stroke and dementia\u003c\/li\u003e\r\n \t\u003cli\u003eReview the sleep anatomy and physiology relevant to neurological disorders\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate strategies to identify sleep disorders and incorporate sleep health in neurological care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp class=\"carina-rte-public-DraftStyleDefault-block\"\u003eSTROKE\u003c\/p\u003e\r\n\r\n\u003cul class=\"carina-rte-public-DraftStyleDefault-ul\"\u003e\r\n \t\u003cli\u003eTreat appropriate acute ischemic stroke patients with modern strategies that   include the extended 24-hour treatment window with thrombolytics,   endovascular approaches and antithrombotic\u003c\/li\u003e\r\n \t\u003cli\u003eEstablish appropriate management of intracerebral hemorrhage according to current guidelines for the management of hypertensive and lobar hemorrhages as well as the role of reversal strategies in coagulopathic hemorrhages\u003c\/li\u003e\r\n \t\u003cli\u003eInstitute measures to prevent a recurrent stroke based on stroke mechanisms and in special populations according to the most recent guidelines and evidence\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n \r\n\r\n\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e5 Tips for the Practicing Clinician- Florida Stroke Registry.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eAdvances in Surgical Neuro-Oncology.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eAn Interesting Case- Tapia Syndrome.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eBrain Death Criteria- An Update for the General Neurologist.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eBuilding a Better Brain- A Precision Medicine Approach to Brain Health.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eCerebrovascular Neurology in Women- Through the Lifecycle.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eChallenging Diagnostic Considerations- Difficult Cases in Cognitive Testing.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Pearls for Complex Headache Disorders.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eCognitive Behavioral Impairment Case Review- CNS Whipple’s Disease.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eCognitive Impairment in MS.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eControversies in Stroke- Acute Management of Patients With Small Infarct Core.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eDecompressive Hemicraniectomy for Malignant Hemispheric Infarction.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eDeep Learning in Neurology.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eDetection of Atrial Fibrillation After Stroke.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis in Multiple Sclerosis- Case Presentations.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eDisparities in Sleep Health and Cognition.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eFocal Epilepsy and Generalized Epilepsy- Cenobamate.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eFood for Thought- Nutritional Health and Wellness in MS.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eFrailty and Cognition- An Understudied Risk Factor in Middle and Older Life.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eGeneralized Epilepsy- Lacosamide \u0026amp; Perampanel.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eHeadache in Cerebrovascular Disorders.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eInflammatory Neuropathies- Autoantibody Testing.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eIntracranial Atherosclerotic Disease- Secondary Stroke Prevention.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eIntractable Pediatric Headache and Episodic Syndromes.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eIschemic Stroke- Large Core Infarction.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eLeft Atrial Appendage Closure for Stroke Prevention.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eMild Traumatic Brain- Perspectives on Identification and Management.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eMindfulness Base Psychotherapy and Epilepsy.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eMOG Antibody Disease (MOGAD) Update.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eMotor and Non-Motor Fluctuations- The Many Faces of ‘Off’ State in Parkinson Disease.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eMovement Disorders Diagnoses- Pitfalls and Pearls.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eMy Stroke Patient is in a Coma.Now What..mp4\u003c\/li\u003e\r\n \t\u003cli\u003eNocturnal Events and Parasomnias.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eOptimizing Patient Care- Collaborative Care Models to Improve Patient and Family Centered Outcomes.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eOverview of Spinal Cord Injury and Evaluation and Management of Autonomic Dysreflexia.mp4\u003c\/li\u003e\r\n \t\u003cli\u003ePsychotherapeutic Interventions for Patients With Neurological Conditions.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eRadiation and CNS Malignancy.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eResponsive Neurostimulation for the Treament of Epilepsy.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eReview of the 2022 Intracerebral Hemorrhage Guidelines.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eRoundtable Discussion- Acute Treatment in Ischemic Stroke.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eSleep- A Risk Factor and Confounder of Cognitive Impairment.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eThe Epigenetic Clock as a Biomarker of Aging- Applications in Cognitive Aging Research.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eThe Role of Optical Coherence Tomography in Neurology.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eTherapeutic Advances in ALS.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eThrombolysis for Acute Ischemic Stroke- TNK, Non- Disabling Stroke and Lysis in the Extended Window.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eUniversity of Miami Roundtable Discussion- Stroke Prevention.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eUpdate on Brain Tumors in Adolescents and Young Adults.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eUpdate on Gliomas.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eUpdate on Sleep Therapeutics- Pharmacotherapy for Insomnia and Hypersomnia.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eWhat is New With Neuromodulation Therapy. Deep Brain Stimulation for Epilepsy.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eWhat’s New in Parkinson’s Disease- Diagnosis and Treatment.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eWhat’s New in Pharmacology for the Management of Treatment Resistant Epilepsy. Lennox-Gastaut Syndrome.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eWhat’s Shaking. Essentials of Essential Tremors- Diagnosis and Treatment.mp4\u003c\/li\u003e\r\n \t\u003cli\u003eWhat’s New in Surgery for Treatment Resistant Epilepsy. Laser Ablation.mp4\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954560733282,"sku":"MED-AMB06101","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/University-of-Miami-Neurology-Update-and-Stroke-Intensive-Review-2023.jpg?v=1779379726","url":"https:\/\/meducourse.com\/products\/university-of-miami-neurology-update-and-stroke-intensive-review-2023","provider":"Meducourse","version":"1.0","type":"link"}